New Covenant Trust Company »

Neurocrine Biosciences shares owned by New Covenant Trust Company

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by New Covenant Trust Company from 13F filings

Historical chart of New Covenant Trust Company investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by New Covenant Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by New Covenant Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 230 137.92

More positions owned by New Covenant Trust Company

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard World Esg Us Stk Etf (ESGV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Esg Intl Stk Etf (VSGX)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Usa Esg Slc (SUSA)
Amazon (AMZN)
Fidelity Covington Trust Fundamental Larg (FFLC)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for New Covenant Trust Company

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Jpmorgan Chase & Co
Bellevue Group
Geode Capital Management
T. Rowe Price Associates
Morgan Stanley
Dodge & Cox
Invesco
AQR Capital Management
DSM Capital Partners
Goldman Sachs Group
Pictet Asset Management Holding SA

View all funds holding Neurocrine Biosciences